Founded with a mission to revolutionize the diagnostic technology landscape, Sapphiros focuses on investing in growth-stage diagnostic companies that emphasize innovation and patient-centric solutions. The company's vision is to make crucial diagnostic results globally accessible, leveraging a portfolio that includes advanced sample collection, next-generation diagnostics, computational biology, and printed electronics. By providing real-time, definitive results, Sapphiros aims to empower global communities to make informed decisions about their health and wellness.
Sapphiros has garnered attention through strategic partnerships and investments in notable diagnostic firms, such as OraSure Technologies, Inc. The company has launched impactful initiatives like Now Future™, which marks a significant step in personalized wellness. With a team of experts and a robust portfolio, Sapphiros has made substantial strides in enhancing the accessibility and accuracy of diagnostic technologies, thereby making a meaningful impact on global healthcare outcomes.
